Add to ORKGRadiology, Nuclear Medicine & Medical ImagingSCI(E)1MEETING ABSTRACT5313P-313P4
SummaryBackgroundApproximately 60–80% of metastatic prostate cancer patients suffer from pain caused...
Radionuclide therapy is widely used as an effective modality in the management of bone pain. The mai...
John Longo,1 Stephen Lutz,2 Candice Johnstone1 1Department of Radiation Oncology, Medical College of...
Objective: To assess the therapeutic efficacy and toxicity of samarium-153-ethylenediaminetetramethy...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Bone seeking radiopharmaceuticals are indicated in cancer patients with multiple painful skeletal me...
We evaluated the pain response and daily discomfort in patients suffering from a borderline degree o...
Primary and metastatic malignant bone lesions result in significant pain and disability in oncology ...
These retrospective study is aimed to evaluate the efficacy of therapy with Stronthium-chloride 89 (...
Bone metastasis is a common sequelae of solid malignant tumors such as prostate, breast, lung, and r...
Introduction: Involvement of the skeleton can cause an excruciating pain in two-thirds of terminal p...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Pain is the commonest clinical manifestation of bone metastases. Its treatment is palliative in natu...
Pain is the commonest clinical manifestation of bone metastases. Its treatment is palliative in natu...
A retrospective analysis was performed on 72 patients with disseminated skeletal metastasis to evalu...
SummaryBackgroundApproximately 60–80% of metastatic prostate cancer patients suffer from pain caused...
Radionuclide therapy is widely used as an effective modality in the management of bone pain. The mai...
John Longo,1 Stephen Lutz,2 Candice Johnstone1 1Department of Radiation Oncology, Medical College of...
Objective: To assess the therapeutic efficacy and toxicity of samarium-153-ethylenediaminetetramethy...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Bone seeking radiopharmaceuticals are indicated in cancer patients with multiple painful skeletal me...
We evaluated the pain response and daily discomfort in patients suffering from a borderline degree o...
Primary and metastatic malignant bone lesions result in significant pain and disability in oncology ...
These retrospective study is aimed to evaluate the efficacy of therapy with Stronthium-chloride 89 (...
Bone metastasis is a common sequelae of solid malignant tumors such as prostate, breast, lung, and r...
Introduction: Involvement of the skeleton can cause an excruciating pain in two-thirds of terminal p...
Intractable bone pain secondary to bone metastasis from prostate or breast cancer, or other malignan...
Pain is the commonest clinical manifestation of bone metastases. Its treatment is palliative in natu...
Pain is the commonest clinical manifestation of bone metastases. Its treatment is palliative in natu...
A retrospective analysis was performed on 72 patients with disseminated skeletal metastasis to evalu...
SummaryBackgroundApproximately 60–80% of metastatic prostate cancer patients suffer from pain caused...
Radionuclide therapy is widely used as an effective modality in the management of bone pain. The mai...
John Longo,1 Stephen Lutz,2 Candice Johnstone1 1Department of Radiation Oncology, Medical College of...